Moneta Group Investment Advisors LLC cut its holdings in Danaher Corporation (NYSE:DHR) by 59.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,176 shares of the conglomerate’s stock after selling 13,424 shares during the period. Moneta Group Investment Advisors LLC’s holdings in Danaher were worth $787,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in Danaher by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after purchasing an additional 520,776 shares in the last quarter. BlackRock Inc. lifted its stake in Danaher by 3.2% in the 2nd quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after purchasing an additional 1,233,876 shares in the last quarter. FMR LLC lifted its stake in Danaher by 0.9% in the 2nd quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after purchasing an additional 183,183 shares in the last quarter. Parnassus Investments CA lifted its stake in Danaher by 0.3% in the 3rd quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after purchasing an additional 29,381 shares in the last quarter. Finally, Flossbach Von Storch AG lifted its stake in Danaher by 17.2% in the 3rd quarter. Flossbach Von Storch AG now owns 6,776,921 shares of the conglomerate’s stock worth $581,324,000 after purchasing an additional 994,902 shares in the last quarter. 76.32% of the stock is owned by institutional investors.
Several analysts have issued reports on the stock. Cowen reiterated a “buy” rating and issued a $90.00 target price on shares of Danaher in a research note on Wednesday, October 4th. Morgan Stanley reiterated an “overweight” rating and issued a $95.00 target price (up from $86.00) on shares of Danaher in a research note on Friday, October 6th. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research note on Thursday, October 5th. Robert W. Baird increased their target price on shares of Danaher from $87.00 to $97.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and issued a $95.00 target price on shares of Danaher in a research note on Friday, September 8th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $93.31.
In related news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total value of $11,671,620.96. Following the transaction, the chief executive officer now owns 271,737 shares in the company, valued at approximately $25,173,715.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the completion of the transaction, the director now owns 104,621 shares in the company, valued at approximately $9,501,679.22. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 273,810 shares of company stock worth $25,218,813. Corporate insiders own 12.20% of the company’s stock.
Shares of Danaher Corporation (DHR) opened at $92.82 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. The firm has a market cap of $65,261.68, a price-to-earnings ratio of 24.12, a PEG ratio of 2.23 and a beta of 1.02. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $94.82.
Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company posted $0.87 EPS. sell-side analysts expect that Danaher Corporation will post 3.99 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/12/05/moneta-group-investment-advisors-llc-has-787000-position-in-danaher-corporation-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.